| Literature DB >> 35263570 |
Josephine R Giles1, Sasikanth Manne2, Elizabeth Freilich3, Derek A Oldridge4, Amy E Baxter2, Sangeeth George5, Zeyu Chen2, Hua Huang6, Lakshmi Chilukuri5, Mary Carberry7, Lydia Giles7, Nan-Ping P Weng8, Regina M Young9, Carl H June10, Lynn M Schuchter7, Ravi K Amaravadi7, Xiaowei Xu11, Giorgos C Karakousis12, Tara C Mitchell7, Alexander C Huang13, Junwei Shi3, E John Wherry14.
Abstract
The clinical benefit of T cell immunotherapies remains limited by incomplete understanding of T cell differentiation and dysfunction. We generated an epigenetic and transcriptional atlas of T cell differentiation from healthy humans that included exhausted CD8 T cells and applied this resource in three ways. First, we identified modules of gene expression and chromatin accessibility, revealing molecular coordination of differentiation after activation and between central memory and effector memory. Second, we applied this healthy molecular framework to three settings-a neoadjuvant anti-PD1 melanoma trial, a basal cell carcinoma scATAC-seq dataset, and autoimmune disease-associated SNPs-yielding insights into disease-specific biology. Third, we predicted genome-wide cis-regulatory elements and validated this approach for key effector genes using CRISPR interference, providing functional annotation and demonstrating the ability to identify targets for non-coding cellular engineering. These studies define epigenetic and transcriptional regulation of human T cells and illustrate the utility of interrogating disease in the context of a healthy T cell atlas.Entities:
Keywords: CD8 T cell differentiation; CRISPR; epigenetic regulation; epigenome engineering
Mesh:
Substances:
Year: 2022 PMID: 35263570 PMCID: PMC9214622 DOI: 10.1016/j.immuni.2022.02.004
Source DB: PubMed Journal: Immunity ISSN: 1074-7613 Impact factor: 43.474